Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Darwin_Knows Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1912010829878239233.png) DarwinKnows [@Darwin_Knows](/creator/twitter/Darwin_Knows) on x XXX followers
Created: 2025-07-14 13:57:52 UTC

Novo Nordisk A/S (Valuation - Expensive)

Novo Nordisk A/S has the best Fundamentals score in Denmark. The fundamentals score is +4. Novo Nordisk A/S has an overall score of +3 and there is one alert. 

The valuation ratios for Novo Nordisk indicate that the stock is currently expensive compared to its peers. The forward P/E ratio is 16.8, while the peer average is only XXX. Similarly, the trailing P/E ratio of XXXX is also above the peer average of XXX. The enterprise value to EBITDA ratio of XXXX is significantly higher than the peer average of -22.9, suggesting that investors are paying a premium for the company's earnings potential. Overall, these metrics indicate that the stock is priced at a premium, leading to an "expensive" valuation rating.



#DarwinKnows #NovoNordiskA/S #NOVO-B $NOVO-B.DK

![](https://pbs.twimg.com/media/Gv0rUV3aMAABZE3.png)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944758245387854166/c:line.svg)

**Related Topics**
[denmark](/topic/denmark)
[$novcde](/topic/$novcde)
[novo](/topic/novo)

[Post Link](https://x.com/Darwin_Knows/status/1944758245387854166)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Darwin_Knows Avatar DarwinKnows @Darwin_Knows on x XXX followers Created: 2025-07-14 13:57:52 UTC

Novo Nordisk A/S (Valuation - Expensive)

Novo Nordisk A/S has the best Fundamentals score in Denmark. The fundamentals score is +4. Novo Nordisk A/S has an overall score of +3 and there is one alert.

The valuation ratios for Novo Nordisk indicate that the stock is currently expensive compared to its peers. The forward P/E ratio is 16.8, while the peer average is only XXX. Similarly, the trailing P/E ratio of XXXX is also above the peer average of XXX. The enterprise value to EBITDA ratio of XXXX is significantly higher than the peer average of -22.9, suggesting that investors are paying a premium for the company's earnings potential. Overall, these metrics indicate that the stock is priced at a premium, leading to an "expensive" valuation rating.

#DarwinKnows #NovoNordiskA/S #NOVO-B $NOVO-B.DK

XX engagements

Engagements Line Chart

Related Topics denmark $novcde novo

Post Link

post/tweet::1944758245387854166
/post/tweet::1944758245387854166